Antifungal effects of new heterocyclic compounds, 6H-pyrimido[2,1-a]isoindole derivatives. 1998

K Nesmĕrák, and H Pelouchová, and V Vsetecka, and I Nĕmec, and J Gabriel
Faculty of Science, Charles University, Prague, Czech Republic.

Minimal inhibitory concentrations for 10 new condensed isoindole derivatives were established by the agar diffusion method. Benzo[b]-6H-pyrimido[2,1-a]isoindole-4-one exhibited a broad antifungal effect; the observed MIC (mg/L) were 7 (K. lactis), 8 (C. pseudotropicalis), 17 (W. fluorescens), 22 (E. magnusii), 31 (P. membranaefaciens), 32 (S. alluvius) and 32 (S. cerevisiae). The compound also inhibited the growth of B. subtilis (MIC 9 mg/L). No effect on the growth of E. coli was found.

UI MeSH Term Description Entries
D007211 Indoles Benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to ISOINDOLES which have the nitrogen away from the six-membered ring.
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D006575 Heterocyclic Compounds, 3-Ring A class of heterocyclic compounds that include a three-ring fused structure. Both aromatic or non-aromatic ring structures are included in this category. Fused Heterocyclic Compounds, Three-Ring,Heterocyclic Cpds, 3 Ring,Three Ring Heterocyclic Compounds,3-Ring Heterocyclic Compounds,Fused Heterocyclic Compounds, Three Ring,Heterocyclic Compounds, 3 Ring
D006576 Heterocyclic Compounds, 4 or More Rings A class of heterocyclic compounds that include four or more fused rings. Both aromatic or non-aromatic ring structures are included in this category. Heterocyclic Compounds with 4 or More Rings,Five Ring Heterocyclic Compounds,Four Ring Heterocyclic Compounds,Fused Heterocyclic Compounds, Five-Ring,Fused Heterocyclic Compounds, Four-Ring,Heterocyclic Compounds with Four or More Rings,Heterocyclic Compounds, 4-Ring,Heterocyclic Compounds, 5-Ring,Heterocyclic Cpds, 4 Ring,Heterocyclic Cpds, 4 or More Rings,Heterocyclic Cpds, 5 Ring,4-Ring Heterocyclic Compounds,5-Ring Heterocyclic Compounds,Fused Heterocyclic Compounds, Five Ring,Fused Heterocyclic Compounds, Four Ring,Heterocyclic Compounds, 4 Ring,Heterocyclic Compounds, 5 Ring
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics

Related Publications

K Nesmĕrák, and H Pelouchová, and V Vsetecka, and I Nĕmec, and J Gabriel
November 1994, Die Pharmazie,
K Nesmĕrák, and H Pelouchová, and V Vsetecka, and I Nĕmec, and J Gabriel
August 2003, Bioorganic & medicinal chemistry letters,
K Nesmĕrák, and H Pelouchová, and V Vsetecka, and I Nĕmec, and J Gabriel
March 1985, Il Farmaco; edizione scientifica,
K Nesmĕrák, and H Pelouchová, and V Vsetecka, and I Nĕmec, and J Gabriel
December 2011, Acta chimica Slovenica,
K Nesmĕrák, and H Pelouchová, and V Vsetecka, and I Nĕmec, and J Gabriel
January 1972, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
K Nesmĕrák, and H Pelouchová, and V Vsetecka, and I Nĕmec, and J Gabriel
November 1963, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
K Nesmĕrák, and H Pelouchová, and V Vsetecka, and I Nĕmec, and J Gabriel
December 1974, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
K Nesmĕrák, and H Pelouchová, and V Vsetecka, and I Nĕmec, and J Gabriel
October 2014, European journal of medicinal chemistry,
K Nesmĕrák, and H Pelouchová, and V Vsetecka, and I Nĕmec, and J Gabriel
January 2018, Combinatorial chemistry & high throughput screening,
Copied contents to your clipboard!